# K990476: HP Viridia Component Monitoring System, HP Viridia CMS 24/26, Model Rev. K with Easi-Ecg Option

- Pathway: 510(k) (Traditional)
- Applicant: Hewlett-Packard GmbH
- Decided: Jul 22, 1999 after 156 days
- Product code: MHX (Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms))
- Device class: 2
- Regulation: 21 CFR 870.1025
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 1 generation back to K872781 (1987). 2 ancestors in all.
437 later devices descend from it; 3 cite it directly.
0 of 440 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K872781: Easi Lead System Cable Assembly, Totemite Medical Electronics (1987) Summary page 1.
- K951370: Zymed Telemetry System; Model T8010, Zymed Medical Instrumentation (1995) Summary page 1.

## Most influential descendants
- K992595: HP Viridia Component Monitoring System, Model Rev. K with Easi-ST Segment Measurement, HP Viridia CMS 24/26, Rev K with (1999), 436 descendants of its own
- K013199: Philips Component Compact Monitor,Model M1275B, Philips Compenent Rack, Model M1276B (2001), 431 descendants of its own
- K021300: Modification of Philips Component Compact Monitor, Release a.03, Model M1275B (2002), 421 descendants of its own
- K020531: Philips Multi-Parameter Module, Model M3001A; Philips Component Compact Monitor, Release a.02, Model M1275B (2002), 416 descendants of its own
- K021778: Philips Component Compact Monitor, Release a.04, Model #M1275B (2002), 407 descendants of its own

## Indications for use
The Hewlett-Packard Viridia Component Monitoring System, (M1175A/76A/77RA), and Viridia 24/26 (M1205A) Rev.K with EASI-ECG Option is indicated for: Assessment of symptoms that may be related to rhythm disturbances of the heart: patients with palpitations, the evaluation of arrhythmia’s in adult and pediatric patients. Assessment of risk in patients with or without symptoms of arrhythmia. Assessment of efficacy of antiarrhythmic therapy. Assessment of pacemaker function. Assessment of symptomatic or asymptomatic patients to evaluate for ischemic heart disease. Assessment is indicated for single-hospital environment.

Source page: https://510kreport.com/device/K990476
Methodology: https://510kreport.com/methodology